Acute Lymphoblastic Leukemia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Condition: Lymphoblastic Leukemia Interventions: Drug: Dexamethasone; Drug: Mitoxantrone; Drug: PEG asparaginase; Drug: Bortezomib; Drug: Vorinostat; Drug: Mercaptopurine; Drug: Methotrexate; Drug: Blinatumomab; Drug: Ziftomenib Sponsors: Stanford University; Pediatric Oncology Experimental Therapeutics Investigators' Consortium; Amgen; Lucile Packard Children's Hospital Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Registry of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia
Conditions: Relapsed/Refractory Acute Lymphoblastic Leukemia; T-cell Acute Lymphoblastic Leukemia Intervention: Sponsor: Versailles Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials